Loading…
Based on limited metadata, Cerno Pharmaceutical received an FDA Warning Letter on May 15, 2018, regarding an unspecified product type classified as "Other." Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The issuing FDA office is also not identified in the metadata provided. To understand the particular regulatory concerns and required corrective actions, the complete warning letter would need to be reviewed.